Sandbox ID Eye: Difference between revisions
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
===Conjunctivitis=== | ===Conjunctivitis=== | ||
* Conjunctivitis, acute | * Conjunctivitis, acute<ref name="pmid24150468">{{cite journal| author=Azari AA, Barney NP| title=Conjunctivitis: a systematic review of diagnosis and treatment. | journal=JAMA | year= 2013 | volume= 310 | issue= 16 | pages= 1721-9 | pmid=24150468 | doi=10.1001/jama.2013.280318 | pmc=PMC4049531 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24150468 }} </ref> | ||
:* Empiric antimicrobial therapy, bacterial | :* Empiric antimicrobial therapy, bacterial | ||
::* Preferred regimen (1): [[Gentamicin]] ointment qid for 1 week {{or}} [[Gentamicin]] solution 1-2 drops qid for 1 week {{or}} [[Tobramycin]] ointment tid for 1 week | ::* Preferred regimen (1): [[Gentamicin]] ointment qid for 1 week {{or}} [[Gentamicin]] solution 1-2 drops qid for 1 week {{or}} [[Tobramycin]] ointment tid for 1 week |
Revision as of 19:30, 2 June 2015
Conjunctivitis
- Conjunctivitis, acute[1]
- Empiric antimicrobial therapy, bacterial
- Preferred regimen (1): Gentamicin ointment qid for 1 week OR Gentamicin solution 1-2 drops qid for 1 week OR Tobramycin ointment tid for 1 week
- Preferred regimen (2): Besifloxacin solution 1 drop 3 times for 1 week OR Ciprofloxacin ointment tid for 1 week OR Ciprofloxacin solution 1-2 drops topical qid for 1 week OR Gatifloxacin solution tid for 1 week OR Levofloxacin solution 1-2 drops qid for 1 week OR Moxifloxacin solution tid for 1 week OR Ofloxacin solution 1-2 drops qid for 1 week
- Preferred regimen (3): Azithromycin ointment bid for 2 days, then 1 drop qd for 5 days OR Erythromycin ointment qid for 1 week
- Preferred regimen (4): Sulfacetamide ointment qid and at bedtime for 1 week OR Sulfacetamide solution 1-2 drops q2-3h for 1 week
- Preferred regimen (5): Trimethoprim/Polymyxin B solution 1 or 2 drops qid for 1 week
- Note: Topical steroids are not recommended for bacterial conjunctivitis.
- Culture-directed antimicrobial therapy
- Methicillin-resistant Staphylococcus aureus
- Preferred regimen: Fortified Vancomycin
- Chlamydia trachomatis
- Inclusion conjunctivitis
- Preferred regimen: Azithromycin 1 g PO qd
- Alternative regimen: Doxycycline 100 mg PO bid for 7 days
- Conjunctivitis secondary to trachoma
- Preferred regimen: Azithromycin 20 mg/kg PO for one single dose
- Alternative regimen (1): Tetracycline OR Erythromycin ointment for 6 weeks
- Alternative regimen (2): Tetracycline PO for 3 weeks OR Erythromycin PO for 3 weeks
- Neisseria gonorrhoeae
- Hyperacute bacterial conjunctivitis, adult
- Preferred regimen: Ceftriaxone 1 g IM once
- Note: Dual therapy to cover Chlamydia is indicated.
- Herpes simplex virus
- Preferred regimen: Acyclovir 1 drop topical 9 times per day OR Acyclovir 400 mg PO 5 times per day for 7-10 days OR Valacyclovir 500 mg PO tid for 7-10 days
- Note: Topical steroids should be avoided.
- Varicella zoster virus
- Preferred regimen: Acyclovir 800 mg PO 5 times per day for 7-10 days OR Famciclovir 500 mg PO tid for 7-10 days OR Valacyclovir 1000 mg PO tid for 7-10 days
- Note: Treatment usually consists of a combination of oral antivirals and topical steroids.
Blepharitis
Endophthalmitis, bacterial
Endophthalmitis, candidal
Endophthalmitis, chronic
Endophthalmitis, mold
Endophthalmitis, post-cataract surgery, acute
Endophthalmitis, post-cataract surgery, chronic
Endophthalmitis, post-tramatic
Keratitis, bacterial
Keratitis, fungal
Keratitis, protozoal
Keratitis, viral
Ocular syphilis
Ocular toxocariasis
Ocular toxoplasmosis
Ocular tuberculosis
Orbital cellulitis
Periocular Infection
Retinal necrosis, acute, CMV
Retinal necrosis, acute, HSV or VZV
Retinal necrosis, progressive outer, VZV
Retinitis, CMV
Stye
Uveitis, acute anterior
Uveitis, Lyme disease
- ↑ Azari AA, Barney NP (2013). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.